| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.0015 | 1 |